Tabula Rasa HealthCare, Inc. (TRHC)

AnewHealth provides transformative pharmacy solutions that elevate care and help providers and payers overcome the unique challenges of caring for the most at-risk patients in healthcare AnewHealth provides transformative pharmacy solutions that elevate care and help providers and payers overcome the unique challenges of caring for the most at-risk patients in healthcare

CLEVELAND, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ExactCare®, a national provider of medication management and comprehensive long-term pharmacy services and a Nautic Partners portfolio company, today announced that the acquisition of Tabula Rasa HealthCare, Inc.®, a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, is complete.

MOORESTOWN, N.J. , Oct. 31, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ("TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based organizations, today announced that its stockholders approved the previously announced acquisition by Nautic Partners ("Nautic"), following which TRHC is expected to combine with ExactCare Pharmacy, a portfolio company of Nautic.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Tabula Rasa HealthCare, Inc. (NasdaqGM: TRHC) to Nautic Partners. Under the terms of the proposed transaction, shareholders of Tabula will receive $10.50 in cash for each share of Tabula that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whethe.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Tabula Rasa HealthCare, Inc. (NasdaqGM: TRHC) to Nautic Partners. Under the terms of the proposed transaction, shareholders of Tabula will receive $10.50 in cash for each share of Tabula that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whethe.

PHILADELPHIA , Aug. 9, 2023 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating the fairness of the proposed buyout of Tabula Rasa HealthCare, Inc. ("Tabula Rasa") (NASDAQ: TRHC) shareholders by private equity firm Nautic Partners ("Nautic") at $10.50 per share . Following the closing of the proposed transaction, Tabula Rasa investors will be cashed out of their investment position and the company's shares will no longer be publicly traded.

The company also announced improved revenue in its second-quarter earnings. The deal is expected to be completed by the fourth quarter of 2023.

Although the revenue and EPS for Tabula Rasa Healthcare (TRHC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Tabula Rasa Healthcare (TRHC) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.14 per share. This compares to loss of $0.32 per share a year ago.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) to Nautic Partners for $10.50 in cash per share is fair to Tabula Rasa shareholders. Halper Sadeh encourages Tabula Rasa shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth.

Tabula Rasa HealthCare Inc shares were 30% higher in premarket trading after news that the healthcare company is to be acquired by private-equity firm Nautic Partners. The all-cash deal is for approximately $570 million, including debt of around $262 million.

Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J. , Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (Nasdaq:TRHC) ("TRHC" or the "Company"), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today reported financial results for the second quarter ended June 30, 2023.

$10.50 Per Share All-Cash Transaction Represents a Significant Premium for Tabula Rasa Stockholders Combination of Two Highly Complementary Companies to Benefit Patients, Providers and Payers with First of its Kind Risk Management Platform in Pharmacy Care Expands the Reach of Tabula Rasa's MedWise Technology Platform to Multiple Provider and Payer Markets MOORESTOWN, N.J. , Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ("TRHC," "Tabula Rasa" or the "Company") (NASDAQ: TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today announced it has entered into a definitive agreement (the "Agreement") to be acquired by Nautic Partners ("Nautic") for $10.50 in cash per share and will combine with ExactCare Pharmacy ("ExactCare"), a portfolio company of Nautic.

MOORESTOWN, N.J. , July 25, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its second quarter 2023 financial results Tuesday, August 8, 2023 at 8:30 a.m.

Tabula Rasa Healthcare (TRHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Tabula Rasa Healthcare (TRHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.